Development of small-molecule-induced fibroblast expansion technologies

Area of Science:

• Cell Biology
• Dermatology
• Regenerative Medicine

Background:

• Dermal fibroblasts are crucial for skin wound healing and extracellular matrix production.
• They are key cells for generating induced pluripotent stem cells (IPSCs) and are used in restorative surgeries.
• Efficient ex vivo fibroblast expansion is vital for skin biology research and bioartificial skin engineering.

Purpose of the Study:

• To identify small molecules that promote ex vivo dermal fibroblast expansion.
• To elucidate the mechanisms underlying small molecule-induced fibroblast proliferation.

Main Methods:

• Screening of 35 small molecules targeting cellular quiescence pathways.
• Analysis of human dermal fibroblast expansion.
• Cell cycle analysis to assess proliferation.
• Evaluation of apoptosis and necrosis levels.

Main Results:

• AS1949490 and SKF96365 significantly increased human dermal fibroblast expansion.
• These molecules promoted cell cycle progression, evidenced by increased S-G2-M phase cells.
• Reduced apoptosis and necrosis were observed in treated fibroblasts.
• Small molecules also induced endogenous expression of IPSC generation, collagen synthesis, and aging-related genes.

Conclusions:

• Identified small molecules enhance dermal fibroblast expansion and viability.
• These compounds may improve bio-filler products by inducing collagen synthesis.
• Potential applications include developing fibroblast products with improved aging profiles and enhancing IPSC generation.